Clinical Trials Browser

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT00034879 2013-01-04

Iressa Expanded Access Program (EAP)

Phase 3 Completed

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT00189358 2010-07-20

A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy

Phase 2 Completed

Gynecologic

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00127829 2009-04-23

AGUS

Phase 1 Completed

66 enrolled

Tumor-Agnostic

Neoplasms

NCT00635973 2009-04-22

Open-Label Extension of Other SZ1839 (Iressa) Trials

Phase 3 Completed

100 enrolled

Tumor-Agnostic

Neoplasms

NCT00135135 2008-06-03

Therapy for Children With Neuroblastoma

Phase 2 Completed

23 enrolled

CNS

Neoplasms, Neuroblastoma

Clinical Trials

BM

Efficacy and Safety of Precision Therapy in Refractory Tumor

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma

Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients

Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck

Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene

Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic Carcinoma

A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer

Iressa Expanded Access Program (EAP)

A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy

AGUS

Open-Label Extension of Other SZ1839 (Iressa) Trials

Therapy for Children With Neuroblastoma